FDA inspection
Societa Italiana Medicinali Scandicci, Srl: FDA inspection ending Apr 12, 2006
FDA inspection 427599 · Official Action Indicated (OAI) · Reggello
Key facts
| Inspection ID | 427599 |
|---|---|
| Firm | Societa Italiana Medicinali Scandicci, Srl |
| FEI number | 3001657436 |
| Address | Localita Carraia |
| City | Reggello |
| Fiscal year | 2006 |
| Inspection end date | Apr 12, 2006 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices|New Drug Evaluation|Product Evaluation: Med Devices |
| Product type | Devices, Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data